Search Results - miguel+lanaspa-garcia

1 Results Sort By:
AMPD2 Inhibitors for Treatment/Prevention of Obesity, Diabetes, Metabolic Syndrome, Fatty Liver and Hypertension
Metabolic syndrome combines a variety of medical disorders including obesity, type 1 diabetes, insulin resistance, and refractory hypertension, all of which increase the risk of developing cardiovascular disease. A research group led by Dr. Richard Johnson has identified the use of a specific variant of adenosine monophosphate deaminase 2 (AMPD2) as...
Published: 11/30/2023   |   Inventor(s): Richard Johnson, Gabriela Garcia, Christopher Rivard, Miguel Lanaspa-Garcia
Disease Areas Endocrine/Metabolism, Endocrine/Metabolism, Endocrine/Metabolism, Endocrine/Metabolism, Hematology
Category(s): Therapeutics
For inquiries, email: cuinnovations@cuanschutz.edu.     © 2024. All Rights Reserved. Powered by Inteum